Literature DB >> 8749692

More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension.

S Geberth1, E Stier, M Zeier, G Mayer, M Rambausek, E Ritz.   

Abstract

Marked variability of age at renal death is noted in autosomal dominant polycystic kidney disease (ADPKD). The hypothesis that the coexistence of primary hypertension and ADPKD within families is associated with earlier renal death was tested. Of a total of 162 ADPKD patients treated in one Austrian and three German centers, 57 propositi were identified whose families provided (1) information concerning blood pressure; (2) documented presence of ADPKD (by sonography or autopsy) in one parent; and (3) age at renal death in the propositus. Hypertension of the unaffected parent was defined as blood pressure above 140/90 mm Hg or antihypertensive treatment before age 60 yr. Age at renal death in the propositus was defined as the start of renal replacement therapy. Median age at renal death of 23 offspring (11 male, 12 female) from families with a history of primary hypertension of the nonaffected parent was lower than that of 34 offspring (16 male, 18 female) from families without a known history of primary hypertension of the nonaffected parent, i.e., 49 yr (26 to 64) versus 54 yr (28 to 82) (P < 0.03). The data are consistent with the notion that genetic predisposition to primary hypertension is associated with an earlier onset of terminal renal failure in families with ADPKD.

Entities:  

Mesh:

Year:  1995        PMID: 8749692     DOI: 10.1681/ASN.V661643

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  7 in total

Review 1.  Recent advances: nephrology.

Authors:  C R Tomson
Journal:  BMJ       Date:  2000-01-08

2.  Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Michel Chonchol; Berenice Gitomer; Tamara Isakova; Xuan Cai; Isidro Salusky; Renata Pereira; Kaleab Abebe; Vicente Torres; Theodor I Steinman; Jared J Grantham; Arlene B Chapman; Robert W Schrier; Myles Wolf
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-13       Impact factor: 8.237

Review 3.  Variable Cyst Development in Autosomal Dominant Polycystic Kidney Disease: The Biologic Context.

Authors:  Wouter N Leonhard; Hester Happe; Dorien J M Peters
Journal:  J Am Soc Nephrol       Date:  2016-08-04       Impact factor: 10.121

Review 4.  Predictors of autosomal dominant polycystic kidney disease progression.

Authors:  Robert W Schrier; Godela Brosnahan; Melissa A Cadnapaphornchai; Michel Chonchol; Keith Friend; Berenice Gitomer; Sandro Rossetti
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

Review 5.  Translational research in ADPKD: lessons from animal models.

Authors:  Hester Happé; Dorien J M Peters
Journal:  Nat Rev Nephrol       Date:  2014-08-19       Impact factor: 28.314

6.  Genotype-phenotype correlation in children with autosomal dominant polycystic kidney disease.

Authors:  Filip Fencl; Jan Janda; Kveta Bláhová; Zdenek Hríbal; Jitka Stekrová; Alena Puchmajerová; Tomás Seeman
Journal:  Pediatr Nephrol       Date:  2009-02-05       Impact factor: 3.714

Review 7.  Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease?

Authors:  Moomal Tasneem; Carly Mannix; Annette Wong; Jennifer Zhang; Gopala Rangan
Journal:  World J Nephrol       Date:  2018-03-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.